[go: up one dir, main page]

WO2001079114A3 - Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content - Google Patents

Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content Download PDF

Info

Publication number
WO2001079114A3
WO2001079114A3 PCT/EP2001/004209 EP0104209W WO0179114A3 WO 2001079114 A3 WO2001079114 A3 WO 2001079114A3 EP 0104209 W EP0104209 W EP 0104209W WO 0179114 A3 WO0179114 A3 WO 0179114A3
Authority
WO
WIPO (PCT)
Prior art keywords
salt
sodium chloride
preparation
water content
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/004209
Other languages
French (fr)
Other versions
WO2001079114A2 (en
Inventor
Maxime Franc
Jean-Marie Blondelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay SA filed Critical Solvay SA
Priority to AU2001265874A priority Critical patent/AU2001265874A1/en
Priority to EP01943248A priority patent/EP1280734A2/en
Publication of WO2001079114A2 publication Critical patent/WO2001079114A2/en
Publication of WO2001079114A3 publication Critical patent/WO2001079114A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/14—Purification
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/40—Table salts; Dietetic salt substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns a salt comprising more than 95 wt. % of sodium chloride having a weight loss less than 1200 mg/kg under the effect of heating at 500 °C for 24 hours; the use of said salt as pharmaceutical salt; preparation thereof by drying a sodium chloride powder at a temperature higher than 300 and lower than 600 °C and a method for measuring water content in a salt sample by measuring loss weight incurred by the sample under the effect of heating at a temperature higher than 450 °C, for at least 24 hours.
PCT/EP2001/004209 2000-04-13 2001-04-12 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content Ceased WO2001079114A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001265874A AU2001265874A1 (en) 2000-04-13 2001-04-12 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content
EP01943248A EP1280734A2 (en) 2000-04-13 2001-04-12 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004797A FR2807747B1 (en) 2000-04-13 2000-04-13 SALT COMPRISING MORE THAN 95% BY WEIGHT OF SODIUM CHLORIDE, USE AND PROCESS FOR PRODUCING SUCH SALT AND METHOD FOR MEASURING THE WATER CONTENT OF SALT
FR00/04797 2000-04-13

Publications (2)

Publication Number Publication Date
WO2001079114A2 WO2001079114A2 (en) 2001-10-25
WO2001079114A3 true WO2001079114A3 (en) 2002-04-18

Family

ID=8849249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/004209 Ceased WO2001079114A2 (en) 2000-04-13 2001-04-12 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content

Country Status (4)

Country Link
EP (1) EP1280734A2 (en)
AU (1) AU2001265874A1 (en)
FR (1) FR2807747B1 (en)
WO (1) WO2001079114A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102765841B (en) * 2012-05-15 2013-09-18 山西三维丰海化工有限公司 Method for recovering 3,5,6-Trichloropyridin-2-ol sodium from 3,5,6-Trichloropyridin-2-ol sodium alkaline hydrolysis wastewater

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2700002A (en) * 1950-02-13 1955-01-18 The United States Of America As Represented By The Secretary Of The Navy Process of treating sodium chloride to render it moisture resistant
US4048288A (en) * 1975-03-14 1977-09-13 The Dow Chemical Company Method for preventing evaporation-condensation caking of sodium chloride at high temperatures
EP0394607A1 (en) * 1989-04-24 1990-10-31 SEKA Gesellschaft für Schutzraumtechnik mbH Method and apparatus for the treatment of brines and polluted mineral salts and their mixtures
DE4425958A1 (en) * 1993-07-22 1995-01-26 Sumitomo Chemical Co Thermal analysis device
FR2761977A1 (en) * 1997-04-11 1998-10-16 Solvay RAW SALT ENRICHMENT PROCESS

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2700002A (en) * 1950-02-13 1955-01-18 The United States Of America As Represented By The Secretary Of The Navy Process of treating sodium chloride to render it moisture resistant
US4048288A (en) * 1975-03-14 1977-09-13 The Dow Chemical Company Method for preventing evaporation-condensation caking of sodium chloride at high temperatures
EP0394607A1 (en) * 1989-04-24 1990-10-31 SEKA Gesellschaft für Schutzraumtechnik mbH Method and apparatus for the treatment of brines and polluted mineral salts and their mixtures
DE4425958A1 (en) * 1993-07-22 1995-01-26 Sumitomo Chemical Co Thermal analysis device
FR2761977A1 (en) * 1997-04-11 1998-10-16 Solvay RAW SALT ENRICHMENT PROCESS

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"Ctalog Handbook of fine chemicals", SIGMA - ALDRICH BV, XP002156183 *
BALAREV ET AL: "Preparation of pure sodium chloride", CHEMICAL ABSTRACTS + INDEXES,US,AMERICAN CHEMICAL SOCIETY. COLUMBUS, vol. 4, no. 84, 26 January 1976 (1976-01-26), XP002050436, ISSN: 0009-2258 *
CHEMICAL ABSTRACTS, vol. 78, no. 6, 12 February 1973, Columbus, Ohio, US; abstract no. 37307, BERESLAVTSEVA, L. F. ET AL: "Preparation of components for studying phase diagrams and properties of alloys of sodium, indium, and zinc chlorides" XP002156185 *
J. FALBE, M. REGITZ: "Römpp Chemie Lexikon, 9. Auflage", 1991, THIEME VERLAG, STUTTGART, XP002156184 *
TR. SEVEROKAVKAZ. GORNOMET. INST. (1970), NO. 28, 55-6 *

Also Published As

Publication number Publication date
WO2001079114A2 (en) 2001-10-25
FR2807747A1 (en) 2001-10-19
EP1280734A2 (en) 2003-02-05
FR2807747B1 (en) 2002-12-06
AU2001265874A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
CA2378148A1 (en) Nematicidal trifluorobutenes
HUP0402026A3 (en) 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0201046A3 (en) Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
HUP0203438A3 (en) 5-(2-substituted-5-heterocyclysulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0300731A3 (en) Valsartan salts, process for their preparation and pharmaceutical compositions thereof
HUP0200409A3 (en) Valdecoxib compositions, process for their preparation and their use
IL150539A0 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
HUP0401160A3 (en) 2,4,5-trisubstituted thiazolyl derivatives having antiinflammatory activity, process for their preparation and pharmaceutical compositions containing them
HUP0103815A3 (en) Substituted pyrazole derivatives condensed with six-membered heterocyclic rings, process for their preparation and pharmaceutical compositions containing them
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
HRP20010564B1 (en) Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
HUP0203836A3 (en) 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
WO2000076933A3 (en) Water-resistant gypsum composition
HUP0103063A3 (en) Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0402640A3 (en) Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands, process for their preparation and pharmaceutical compositions thereof
FR2773955B1 (en) DIETETIC COMPOSITION IN THE FORM OF A SALT SUBSTITUTING TABLE SALT
EP2017269A9 (en) A pharmaceutical composition comprising form II crystalline Ritonavir and a preparation thereof
AU2001286003A1 (en) Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
CA2347074A1 (en) Pourable aqueous boron-containing compositions and their preparation
CA2219311A1 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them
FR2833259B1 (en) PROCESS FOR THE PREPARATION OF 2-ARYLBENZOFURANES, INTERMEDIATE COMPOUNDS, 2-ARYLBENZOFURANES AND COMPOSITIONS COMPRISING THE SAME

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001943248

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001943248

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001943248

Country of ref document: EP